Fed. Circ. Says Drugmaker Can't Appeal Novartis PTAB Win
The Federal Circuit on Thursday tossed Argentum Pharmaceuticals' appeal of a Patent Trial and Appeal Board decision that found it failed to prove the invalidity of a patent on Novartis' multiple...To view the full article, register now.
Already a subscriber? Click here to view full article